(WASHINGTON) -- The Food and Drug Administration has rejected another diet pill. This one, Qnexa, is the third one the panel has turned down this month.
The FDA wasn't expected to approve the medication because a panel of outside experts voted in 10-6 in July against recommending approval for the combination drug -- made by Vivus -- which was shown in the company's clinical trials to be effective in helping obese and overweight patients lose an average of 6-10 percent of their body weight.
At the meeting, one panelist said the drug is "far superior to anything on the market." However, concerns over psychiatric and cardiovascular issues uncovered in the company's trials ultimately trumped the weight-loss benefit.
Copyright 2010 ABC News Radio